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Abstract	
Background: Apathy is a complex multidimensional syndrome, frequently reported in 
Alzheimer’s disease (AD) and is associated with impaired awareness. Here we present a 
psychometrically robust method to profile apathy in AD. Objectives: To determine the 
validity and reliability of a multidimensional apathy measure, the Dimensional Apathy	Scale	(DAS),	and	explore	the	apathy	subtype	profile	and	its	associations	in	AD.	Methods:	102	people	with	AD	and	55	healthy	controls	were	recruited.	Participants	completed	the	DAS,	the	Apathy	Evaluation	Scale	(AES),	Geriatric	Depression	Short	form	(GDS-15)	and	Lawton	Instrumental	Activities	of	Daily	Living	(LIADL).	Psychometric	properties	of	the	DAS	were	determined.	AD-Control	comparison	was	performed	to	explore	group	differences	on	the	DAS.	Latent	Class	Analysis	(LCA)	was	used	to	explore	the	profile	of	apathy	in	AD.	Results:	The	DAS	had	a	good	to	excellent	Cronbach's	standardized	alpha	(self-rated	=	0.85,	informant/carer-rated	=	0.93),	good	convergent	and	divergent	validity	against	standard	apathy	(AES)	and	depression	(GDS-15)	measures.	Group	comparison	showed	people	with	AD	were	significantly	higher	for	all	apathy	subtypes	than	controls	(p	<	.001),	and	lacking	in	awareness	over	all	apathy	subtype	deficits.	LCA	showed	3	distinct	AD	subgroups,	with	42.2%	in	the	Executive-Initiation	apathy,	28.4%	in	the	Global	apathy	and	29.4%	in	the	Minimal	apathy	group.	Conclusions:	The	DAS	is	a	psychometrically	robust	method	of	assessing	multidimensional	apathy	in	AD.	The	apathy	profiles	in	AD	are	heterogeneous,	with	additional	specific	impairments	relating	to	awareness	dependent	on	apathy	subtype.	
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Introduction	Apathy,	as	a	lack	of	motivation	[1],	is	frequently	reported	as	the	most	prominent	behavioral	syndrome	in	Alzheimer’s	disease	(AD),	and	is	associated	with	global	disease	severity	and	level	of	cognitive	impairment	[2,	3],	and	has	a	negative	predictive	role	in	clinical	course	[4].	Furthermore,	it	has	been	observed	in	predementia	stages	[5].	Apathy	in	AD	is	also	associated	with	increased	caregiver	distress	and	burden	[6]	as	well	as	functional	decline	[7]	making	it	a	negatively	impactful	behavioral	symptom.	There	is	also	a	pervasive	association	between	increased	apathy	and	anosognosia,	or	lack	of	awareness	in	AD	[8].	Although	apathy	related	anosognosia	has	been	observed	in	earlier	stages	of	the	disease	course	[9,	10],	it	has	also	been	suggested	that	this	might	be	due	to	progression	of	neuropathology	[7]	with	individuals	later	in	the	illness	showing	both	symptoms.	Mograbi	and	Morris	[11]	further	reinforced	this	and	proposed	that	apathy	increases	with	lack	of	awareness	of	failures	in	cognitive	tasks	(error	monitoring),	while	emotional	reactions	in	response	to	experiences	of	illness	or	deficit	(emotional	reactivity),	bearing	similarity	to	awareness,	remained	relatively	intact.	They	further	dichotomized	apathy	against	depression,	in	that	the	former	is	associated	with	more	anosognosia.			However,	previous	research	has	shown	some	evidence	that	apathy	is	multidimensional	e.g..	[1,	12],	with	the	proposed	diagnostic	criteria	of	apathy	recognizing	the	syndromatic	nature	of	apathy	[13,	14]	but	without	a	thorough	measurement	of	specific	subtypes	[15].	This	has	been	observed	in	dementia	using	traditional	one-dimensional	assessment	tools	such	as	the	Neuropsychiatric	Inventory	(NPI)	[16].	An	example	of	this	is	that	people	with	dementia	who	endorse	more	emotionally	apathetic	statements	were	more	apathetic	overall,	and	specifically	showed	more	extreme	and	variable	behavioral	
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problems	such	as	insensitivity	and	uncooperativeness	[17].	A	further	study	by	Quaranta	et	al.	[18]	using	the	NPI	found	there	to	be	differing	apathy	characteristics	between	AD	and	frontotemporal	dementia,	where	the	latter	were	reported	to	more	frequently	endorse	statements	relating	to	a	lack	of	initiation,	decreased	emotional	output	and	diminished	interest	towards	friends	or	family.	However,	the	NPI	is	a	tool	designed	to	assess	apathy	amongst	other	behavioral	impairments	and	does	not	examine	apathy	multidimensionally.	Similarly,	the	Apathy	Evaluation	scale	(AES)	[19]	is	a	gold-standard	one-dimensional	measure	for	assessing	apathy	but	is	thought	to	be	composed	of	4	factors,	called	cognitive,	behavioral,	emotional	and	‘other’,	which	have	been	used	by	previous	research	to	calculate	factorial	subscores	e.g.	[20].	However,	these	factors	are	not	consistently	reported	in	other	research,	e.g.	[21],	and	the	AES	has	only	been	validated	as	a	one-dimensional	measure	of	apathy	[15].	The	Scale	for	Assessment	for	Negative	Symptoms	[22]	is	also	less	commonly	used	measure		of	different	types	of	negative	symptoms,	affective	blunting,	avolition/apathy	and	social/emotional	withdrawal,	which	have	overlap	with	some	apathy	subtypes.	More	recently,	Lille	Apathy	Rating	Scale	(LARS)	has	been	validated	in	a	group	of	mixed	dementia	patients	[23]	but	measures	uncorroborated	factorial	subscores	of	apathy.		At	a	neurobiological	level,	a	perfusion	imaging	study	using	the	Apathy	Inventory	(AI)	[24],	a	simple	multidimensional	measure,	observed	that	cognitive,	behavioral	and	affective	components	of	apathy	were	mediated	by	specific	fronto-subcortical	metabolic	circuits	[25].	Initiative	aspects	of	apathy	were	negatively	associated	with	right	anterior	cingulate	cortex	perfusion	with	emotional	blunting	aspects	negatively	associated	with	perfusion	in	right	middle	orbitofrontal	gyrus	in	AD.	Later	structural	imaging	research,	once	more	using	the	AI,	found	that	both	in	AD	and	Progressive	Supranuclear	Palsy	there	
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was	distinct	neuroanatomical	basis	for	Initiative	apathy	relating	to	anterior	cingulate	cortex,	and	Emotional	blunting	aspects	of	apathy,	relating	to	structural	change	insular	cortex	[26].	However,	the	AI	was	found	not	be	a	comprehensive	or	robust	measure	of	multidimensional	apathy	[15].		Apathy	is	thought	to	be	associated	with	prefrontal	cortex-basal	ganglia	circuit	dysfunction,	manifesting	as	different	subtypes	of	apathy,	proposed	in	Levy	and	Dubois	[27,	28]	model.	The	Dimensional	Apathy	Scale	(DAS)	[29]	has	been	designed	to	assess	different	apathy	subtypes	by	a	subscale-based,	quantitative	method	that	has	been	validated	in	amyotrophic	lateral	sclerosis	[30]	and	Parkinson’s	disease	[31].	The	DAS	measures	lack	of	motivation	for	planning,	attention	and	organization	(Executive	apathy),	indifference	or	emotional	neutrality	(Emotional	apathy)	and	self-generation	of	though	(Initiation	apathy).	This	Dimensional	Apathy	framework	relates	to	different	manifestation	of	demotivation,	taking	in	to	account	both	observable	behavioral	symptoms	and	cognitive	deficits.	While	there	are	one-dimensional	apathy	tools	that	have	been	validated	in	AD,	there	are	limited	comprehensive,	validated	tools	assessing	subtypes	of	apathy	in	this	very	common	condition	[15].		The	primary	aim	of	this	study	is	to	validate	the	DAS	in	a	sample	of	people	with	AD	and	their	carers.	Furthermore,	the	profile	of	multidimensional	apathy	in	AD	was	explored	both	through	group	comparison	and	latent	profiling	of	AD	based	on	the	DAS,	so	as	to	determine	subgroups	based	on	the	profile	of	scores	across	the	three	apathy	subtypes.	Finally,	relevant	links	between	the	DAS,	disease	and	functional	variables	will	be	explored.		
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Materials	and	Methods	
Subjects	People	with	AD	and	their	carers	were	recruited	through	Join	Dementia	Research	Platform	and	by	the	Health	Information	Centre	(HIC)	through	the	Scottish	Dementia	Research	Interest	Register	(SDRIR),	as	described	previously	[32].	People	with	AD	were	approached	through	their	carers	to	participate	in	the	study.	This	was	set	up	under	the	support	of	the	Scottish	Dementia	Clinical	Research	Network	(SDCRN)	in	2008	to	facilitate	dementia	research	by	providing	access	to	suitable	potential	recruits	in	Scotland.	Participants	on	the	SDRIR	were	people	referred	by	their	clinicians,	who	have	a	diagnosis	of	dementia	or	a	related	cognitive	disorder	and	have	consented	(or	in	cases	where	the	person	lacked	capacity,	through	his/her	legal	representative).	People	with	AD	were	diagnosed	using	the	ICD-10	when	joining	the	SDRIR	[32]	and	those	on	Join	Dementia	Research	Platform	were	diagnosed	with	the	ICD-10	criteria	aligned	with	NHS	Scotland	practice.	Exclusion	criteria	for	people	with	AD	included	those	with	Clinical	Dementia	Rating	=	3	(due	to	severity	of	dementia),	severe	diabetes,	epilepsy,	alcohol/substance-related	disorders,	severe	head	injury	(that	required	intensive	care	hospitalization),	traumatic	brain	injury	(inclusive	of	subarachnoid	hemorrhage)	and	present	or	past	other	significant,	comorbid	medical	illness	(such	as	stroke,	Parkinson’s	disease,	psychiatric	disease	etc.).	All	people	with	AD	that	were	recruited	community-dwelling.		Additionally,	healthy	controls	were	recruited	from	the	University	of	Edinburgh	Volunteer	Research	Panel.	They	were	prescreened	before	recruitment	with	the	exclusion	criteria	of	severe	diabetes,	epilepsy,	alcohol/substance-related	disorders,	severe	head	injury	(that	required	intensive	care	hospitalization),	traumatic	brain	injury	
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(inclusive	of	subarachnoid	hemorrhage)	and	present	or	past	other	significant,	comorbid	medical	illness	(such	as	stroke,	Parkinson’s	disease,	psychiatric	disease	etc.).	Controls	were	not	specifically	assessed	for	cognitive	impairment	in	the	present	study,	although	were	excluded	if	information	on	the	University	of	Edinburgh	Volunteer	Research	Panel	database	indicated	cognitive	impairment.		
Procedure	and	Assessments	This	was	a	postal	questionnaire	study	where	carers	of	people	with	AD	were	sent	packs	containing	information	sheets,	consent	forms	and	questionnaires	regarding	demotivation/apathy,	mood	and	functional	abilities	of	the	person	with	AD.	The	carer-rated	pack	asked	the	carers	to	complete	the	questionnaires	based	on	their	observations	of	the	people	with	AD	and	the	self-rated	pack	asked	people	with	AD	to	self-rate	their	own	demotivation/apathy	and	mood.	Pre-paid,	addressed	envelopes	were	provided.	
	Both	the	carer-rated	and	self-rated	packs	contained	the	DAS	[29,	30],	Apathy	Evaluation	Scale	(AES)	[19]	and	the	Geriatric	Depression	Scale-Short	form	(GDS-15)	[33,	34]	and	the	carers	completed	the	Lawton	Instrumental	Activities	of	Daily	Living	(LIADL)	[35].	The	DAS	is	a	24-item	scale	that	was	used	to	measure	multidimensional	apathy.	Executive,	Emotional	and	Initiation	apathy	were	assessed	by	subscales	where	each	item	was	rated	on	a	4	point	Likert	scale,	with	the	minimum	score	for	each	subscale	being	0	(least	apathy)	and	24	(most	apathy).	The	DAS	total	score	ranges	from	0	to	72.		DAS	subscale	impairment	cutoffs	were	calculated	on	the	basis	of	≥2	SD	above	the	mean	of	the	control	sample.	Parallel	self-	rated	and	informant/carer-rated	versions	were	used.	The	AES	was	used	as	an	18-item,	gold-standard	measure	of	unidimensional	apathy	scored	on	a	4	point	Likert	scale,	where	18	indicated	least	apathy	and	72	indicated	most	
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apathy.	Cutoffs	of	>36.5	for	the	self-rated	and	>41.5	for	the	carer-rated	versions	were	used	[21].	Furthermore,	the	AES	is	composed	of	a	4	factor	substructure,	Cognitive,	Behavioral,	Emotional	and	Other	factors	[19],	where	subfactorial	scores	can	be	calculated.	Parallel	self-	rated	and	carer-rated	versions	were	used.	The	GDS-15	is	a	15-item	screen	used	to	assess	depression	using	a	dichotomous	scale,	with	scores	ranging	from	0	(not	depressed)	to	15	(most	depressed).	A	clinical	cut-off	of	>6	was	used	to	indicate	presence	of	depression	[36].	Parallel	self-	rated	and	carer-rated	versions	were	used.	The	LIADL	is	an	8-item	carer-rated	assessment	of	the	functional	independence	of	the	person	with	AD,	with	total	scores	ranging	from	0	(low	function,	dependent)	to	8	(high	function,	independent).		The	Mini	Mental	State	Exam	(MMSE)	[37]	and	the	Addenbrooke’s	Cognitive	Examination-Revised	(ACE-R)	[38]	as	measures	of	cognitive	functioning	were	available	from	the	Join	Dementia	Research	Platform	and	SDRIR.		Ethical	approval	was	obtained	from	the	National	Health	Service	(NHS)	South	East	Scotland	Research	Ethics	Committee	01	and	the	School	Philosophy,	Psychology	and	Language	Sciences	(PPLS),	University	of	Edinburgh	Ethical	Committee,	in	accordance	with	the	Declaration	of	Helsinki.	Informed	consent	was	obtained	from	all	participants.	
	
Statistical	analysis	R	and	SPSS	statistics	V21.0	were	used	for	analysis.	Independent	t-tests	and	Chi	squared	tests	were	used	to	compare	demographics	and	clinical	variables	of	the	people	with	AD.	Psychometric	properties	of	the	DAS	were	determined	through	Cronbach’s	Standardized	alpha	(internal	consistency	reliability)	[39]	and	Holm	corrected	Pearson’s	correlations	
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between	DAS	subscales	and	the	AES	(convergent	validity)	and	GDS-15	(discriminant	validity).	A	3	x	3	mixed	design	ANOVA	was	used	for	comparison	of	Group	(AD	Informant/carer-rated	vs	AD	Self-rated	vs	Control	Self-rated)	and	DAS	subscale	(Emotional	vs	Executive	vs	Initiation),	with	post	hoc	Tukey’s	Honest	Significant	Differences	(Tukey’s	HDS)	tests.		Holm	corrected	Pearson’s	correlations	were	used	to	examine	clinical	variable	association	with	awareness	discrepancy	of	people	with	AD	on	DAS	apathy	subscales.	Apathy	subtype	awareness	discrepancy	was	calculated	through	subtracting	informant/carer-rated	scores	from	self-rated	scores.			Latent	class	analysis	(LCA)	was	used	to	investigate	clustering	or	classifying	of	people	with	AD	based	on	the	profile	of	informant/carer-rated	scores	on	the	DAS	subscales	using	Mclust	package	in	R	[40].	Mclust	is	a	model-based	clustering,	classification	and	density	estimation	software	that	is	based	on	finite	Gaussian	mixture	modelling.	In	Mclust,	the	optimal	LCA	model	and	number	of	clusters/classes	are	automatically	selected	according	to	Bayesian	information	criterion	(BIC)	[41].	Furthermore,	the	Integrated	Classification	Likelihood	(ICL)	criterion	[42]	was	also	applied	to	substantiate	optimal	model	selection.	A	one-way	MANOVA	was	used	to	confirm	AD	classes	(subgroups)	selected	through	LCA	based	on	DAS	subscales	differences.	Class	subgroupings	were	classified	based	on	their	DAS	scores	and	then	compared	on	clinical	and	demographic	variables	using	Chi	squared	tests	and	one-way	ANOVAs	(Holm	corrected)	with	significant	results	followed	up	by	post	hoc	Tukey’s	HDS	tests.		
Results	315	people	with	AD	and	their	carers	were	recruited.	There	were	a	total	of	102	AD	carers	that	returned	the	survey	pack,	with	17.6%	being	carers	for	people	with	early	
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onset	AD	(below	the	age	of	65	years	old).	The	most	common	carer	relationship	to	the	person	with	AD	was	spouse.	Of	those,	55	people	with	AD	returned	their	self-rated	packs.	55	healthy	controls	were	recruited.	Table	1	shows	AD	and	healthy	control	groups’	clinical,	demographic,	apathy	and	depression	characteristics.		 TABLE	1	HERE		Table	1	shows	that	there	was	no	significant	difference	between	people	with	AD	and	controls	on	gender	and	years	of	education.	However,	while	the	AD	group	was	significantly	older	than	the	control	group,	there	was	no	significant	age	associated	correlations	between	the	AES	and	GDS-15,	for	both	self-	and	carer-ratings.	People	with	AD	scored	significantly	higher	on	the	AES	and	GDS-15	self-rated	measures	when	compared	to	controls.	76.5%	of	people	with	AD	scored	above	cut-off	on	the	AES	(carer-rated)	and	52.7%	of	people	with	AD	scored	above	cut-off	on	the	GDS-15	(carer-rated).		For	the	N	=	55	where	both	people	with	AD	and	their	carers	returned	the	packs,	the	AD	informant/carer-ratings	(mean	=	46.6,	SD	=	9.9)	were	significantly	higher	than	AD	self-ratings	(mean	=	38.9,	SD	=	9.0)	on	the	AES	(t(108)	=	2.049,	p	<	.001),	with	no	significant	difference	on	the	GDS-15.			
Psychometric	Properties	of	the	DAS	The	DAS	Cronbach’s	Standardized	alpha	value	for	the	informant/carer-rated	version	was	0.93	and	the	self-rated	version	was	0.85,	which	is	excellent	and	good,	respectively.	At	a	DAS	subscale	level,	Executive	(informant/carer	=	0.89,	self	=	0.86)	and	Initiation	
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(informant/carer	=	0.88,	self	=	0.84)	subscales	were	good.	The	informant/carer-rated	Emotional	subscale	was	acceptable	(0.73),	self-rated	version	was	questionable	(0.54).		 TABLE	2	HERE		Table	2	shows	that	DAS	subscales	correlated	positively	with	the	AES,	with	the	self-rated	Executive	and	Emotional	correlating	moderately	and	Initiation	correlating	strongly	with	the	AES	compared	to	the	GDS-15.	Supplementary	Table	1	shows	intercorrelations	of	DAS	subscales	and	the	4	subfactorial	scores	of	the	AES.	
	
Alzheimer’s	disease	apathy	profiling	
Group	Comparison	
	 FIGURE	1	HERE		Figure	1	shows	the	AD	informant/carer-rated,	AD	self-rated	and	control	self-rated	group	comparison	on	different	DAS	subscales.	There	was	a	significant	main	effect	of	Group	(F(1,489)	=	223.1,	p	<	.001)	and	main	effect	of	Subscale	(F(2,489)	=	40.0,	p	<	.001).	There	was	a	significant	Group	and	Subscale	interaction	(F(2,489)	=	12.8,	p	<	.001),	which	seemed	to	be	driven	by	the	difference	between	people	with	AD	and	controls	on	Executive	and	Initiation	apathy,	more	so	than	Emotional	apathy,	as	can	be	observed	in	Figure	1.	Post	hoc	analysis	showed	that	people	with	AD	scored	significantly	higher	on	all	subscales,	both	on	self-rated	(Executive:	p	<	.001;	Emotional:	p	<	.01;	Initiation:	p	<	.001)	and	informant/carer-rated	(Executive:	p	<	.001;	Emotional:	p	<	.001;	Initiation:	p	<	.001),	when	compared	to	control	self-ratings.	AD	informant/carer-ratings	
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were	found	to	be	significantly	higher	than	AD	self-ratings	informant/carers-ratings	over	all	subscales	indicative	of	a	mean	3.4	point	Executive	(p	<	.01),	1.7	point	Emotional	(p	<	.05)	and	2.9	Initiation	(p	<	.01)	apathy	subscale	discrepancy	in	awareness.		Furthermore,	when	examining	clinical	variable	associations,	the	DAS	subscale	scores	(both	self-rated	and	informant/carer-rated)	were	not	significantly	correlated	with	disease	duration.	Also,	no	significant	correlations	were	observed	between	the	discrepancy	scores	on	any	of	the	DAS	subscales	and	disease	duration.	
	
Latent	Class	Analysis		 FIGURE	2	HERE		For	the	LCA	of	informant/carer-ratings	for	AD,	comparison	of	different	models	showed	that	a	model	“VVI”	(diagonal,	varying	volume	and	shape)	supporting	a	3-class	solution	yielded	a	best	fitting	model	with	a	BIC	value	of	-710.2.	The	second	best	model	was	“VVV”	(ellipsoidal,	varying	volume,	shape,	and	orientation)	with	2-classes,	presenting	with	a	BIC	value	of	-714.9.	This	was	a	4.7	point	difference	from	the	initial	model,	which	was	considered	supportive	of	the	3-class	“VVI”	model	[43].	The	ICL	criterion	additionally	supported	3-class	solution	“VVI”	(diagonal,	varying	volume	and	shape)	model	with	a	ICL	value	of	-721.9.	A	one-way	MANOVA	showed	a	significant	difference	the	DAS	subscales,	supporting	3-class	solution	(F(6,	194)	=	53.1,	p	<	.001;	Wilk's	Λ	=	0.1,	partial	η2	=	.6).	Figure	2	illustrates	the	DAS	profiles	of	the	different	classes	and	Table	3	shows	the	DAS,	demographic	and	clinical	characteristics	of	the	classes.		
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Class	1	was	the	largest	(N=43)	and	was	characterized	by	displaying	at	least	one	apathy	subtype.	Table	3	shows	higher	scores	on	the	Initiation	and	Executive	apathy	subscales.	Also,	using	abnormality	cutoffs,	58%	in	this	group	were	impaired	on	at	least	two	apathy	subscales,	the	most	common	of	which	was	Executive	and	Initiation	apathy,	with	only	37%	displaying	global	apathy	over	all	DAS	subscales	and	5%	displaying	one	apathy	subscale.	This	group	was	called	the	Executive	and	Initiation	Apathy	group.	Class	2	was	marginally	the	smallest	group	(N=29)	but,	unlike	Class	1,	displayed	distinctly	most	well	defined	characteristics,	with	highest	mean	scores	over	all	apathy	subscales.	Abnormality	cutoffs	showed	97%	displaying	global	apathy	over	all	DAS	subscales.	This	group	was	called	the	Global	Apathy	group.	Class	3	(N=30)	was	comparatively	lower	in	mean	scores	on	all	apathy	subscales,	where	53%	showing	no	apathy	subscale	impairment,	with	30%	displaying	one	apathy	subtype	impairment	and	17%	displaying	multiple	apathy	subscale	impairments,	based	on	abnormality	cutoffs.	This	was	called	the	Minimal	Apathy	group.	
	 TABLE	3	HERE		Table	3	shows	confirmation	of	subgroup	(class)	differences	based	on	DAS	subscales	and	the	AES	showing	a	significant	difference	between	the	Executive	and	Initiation	apathy,	Global	apathy	and	Minimal	apathy	groupings.	The	subgroups	were	also	found	to	differ	significantly	on	depression	(GDS-15).	Post	hoc	tests	showed	that	the	Minimal	apathy	group	was	significantly	less	depressed	compared	to	the	Executive	and	Initiation	apathy	subgroup	(p	<	.001)	and	the	Global	apathy	subgroup	(p	<	.001).	However	no	such	difference	was	found	between	the	Executive	and	Initiation	apathy	subgroup	and	the	Global	apathy	subgroup.	There	were	no	other	significant	differences	on	other	variables.	
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Discussion	This	study	showed	that	the	DAS	is	a	valid	and	reliable	instrument	for	detecting	multidimensional	apathy	in	AD,	where	the	self-	and	informant/carer-rated	versions	had	a	good	to	excellent	internal	consistency	reliability	and	good	convergent	validity	against	an	existent	gold-standard	measure	of	apathy	(AES).	Specifically,	Executive	and	Initiation	apathy	(both	self-	and	informant/carer-rated	versions)	were	found	to	be	valid	and	reliable,	whereas	the	self-rated	Emotional	apathy	was	less	so.		Though,	self-rated	DAS	Emotional	apathy	was	only	significantly	associated	with	the	Emotional	subfactorial	score	of	the	AES	(Supplementary	Table	1),	showing	a	specific	level	of	convergence	within	these	domains	and	subscale-factor	specific	validity	for	the	DAS	Emotional	apathy	subscale.	Nevertheless,	the	informant/carer-rated	DAS	was	found	to	be	more	psychometrically	robust,	which	is	likely	due	to	the	well-documented	lack	of	awareness	of	apathy	associated	with	cognitive	deficits	in	AD	[8,	24,	44].	This	is	also	in	concordance	with	more	traditional	instruments’	reliance	on	external	ratings,	such	as	the	NPI	[16].	The	discriminant	validity	was	shown	to	be	good,	where	Emotional	apathy	was	not	associated	with	depression,	which	supports	the	distinction	between	these	two	respective	concepts	of	emotional	neutrality	and	emotionality	previously	observed	[30,	31].		Overall	in	the	group	comparison,	Global	apathy	was	observed	in	AD,	both	for	self-ratings	and	informant/carer-ratings,	but	at	varying	degrees.	However,	the	difference	between	people	with	AD	and	controls	self-ratings	on	Executive	and	Initiation	subscales	was	found	to	be	significant	(6.6	points	and	5.8	points,	respectively),	with	Emotional	apathy	being	much	lower	(2.2	points)	but	still	significant.	The	LCA	supported	the	
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presence	of	distinct	profiles	of	apathy	within	AD,	showing	subgroups	of	people	with	AD	displaying	Executive	and	Initiation	apathy,	Global	apathy	and	Minimal	apathy.	The	largest	of	these	groups	was	the	Executive	and	Initiation	apathy	subgroup	(N=43),	which	was	reinforced	by	people	with	AD	and	controls	self-rating	group	comparison	and	magnitude	of	difference	between	the	Executive	and	Initiation	apathy	subscales.	As	one	of	the	most	prominent	behavioral	symptoms	in	AD,	cognitive	impairment	is	also	associated	with	apathy	[45-47].	While	memory	impairment	is	common	in	AD,	attention	[48]	and	executive	dysfunction	[49],	such	as	planning,	spatial	navigation	attention	[50-52]	and	verbal	fluency	[53]	are	also	particularly	noted	to	be	impaired	as	the	disease	progresses	to	later	stages,	which	is	particularly	relevant	to	our	sample	which	is	more	impaired.	However,	it	is	important	to	differentiate	between	the	DAS	Executive	apathy	items	and	executive	functioning	assessments,	wherein	the	overt,	observational	assessments	of	the	former	and	the	performance-based	assessment	of	the	latter,	are	unlikely	to	fully	overlap	but	are	more	likely	to	measure	similar	elements	relating	to	demotivation	towards	planning,	organization	and	attention.	Additionally,	deficits	of	emotional	processing,	social	awareness	[54]	and	emotional	decision-making	[55]	have	also	been	observed	in	AD,	but	may	not	be	a	defining	deficit	of	the	disease.	More	recent	research	using	the	LARS	showed	that	people	with	AD	showed	less	apathy	in	the	“emotional”	dimension	and	the	“self-awareness”	dimension	when	compared	to	people	with	behavioral	variant	frontotemporal	dementia	[56]	and	supports	our	findings	of	Emotional	apathy	as	not	a	hallmark	of	AD.	While	the	Dimensional	Apathy	framework	attempts	to	incorporate	observable	behavioral	and	neuropsychological	deficits,	similar	to	Levy	and	Dubois	[27,	28],	how	apathy	subtypes	map	on	to	cognitive	functioning	is	yet	to	be	determined.	This	will	give	insight	in	to	overlapping	mechanisms	of	motivation	and	cognition.	
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	Further	exploration	showed	that	while	awareness	over	all	apathy	subtypes,	as	assessed	through	a	discrepancy	of	AD	self-rating	and	informant/carer	rating,	was	significantly	impaired	in	AD,	Executive	and	Initiation	apathy	was	most	impaired,	while	Emotional	apathy	was	less	impaired	in	magnitude.	Anosognosia	and	apathy	has	been	particularly	related	to	executive	dysfunction,	where	AD	patients	show	a	lack	of	awareness	of	errors	in	these	tasks	[11].	Furthermore,	this	type	of	error	monitoring	has	been	found	to	be	associated	with	the	anterior	cingulate,	an	area	implicitly	associated	with	Levy	and	Dubois	subtypes	[27,	28].	In	addition,	Mograbi	and	Morris	suggest	dissociation	between	impairment	in	awareness	of	their	disease	state	and	associated	deficits,	while	emotional	reactivity	remaining	intact	in	AD.	This	is	consistent	with	our	findings	in	this	study,	where	the	difference	observed	between	AD	informant/carer-ratings	and	self-ratings	on	the	Emotional	apathy	subscale	were	smaller	than	on	the	other	subscales.	We	also	found	no	significant	difference	on	the	standardized	depression	measure	between	AD	self-	and	informant/carer-ratings,	providing	further	support	that	emotional	aspects	of	functioning,	both	neutral	(apathy)	and	negative	(depression)	are	not	prone	to	the	awareness	deficits.	In	the	scope	of	previous	research,	amyotrophic	lateral	sclerosis	and	Parkinson’s	disease	[30,	31]	have	not	shown	apathy	awareness	deficits,	which	could	suggest	this	is	specific	to	dementia.	Furthermore,	this	adds	the	construct	of	apathy	subtype	awareness	to	the	emerging	Dimensional	Apathy	framework	that	can	be	measured	through	discrepancy	scores	between	self-	and	informant-carer	ratings.	Future	research	should	aim	to	explore	how	this	apathy	subtype	awareness	deficit	changes	longitudinally	over	the	course	of	the	disease.		
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Furthermore,	both	the	Executive	and	Initiation	apathy	as	well	as	the	Global	apathy	subgroups,	were	observed	to	score	higher	on	depression	compared	to	the	Minimal	apathy	subgroup.	Due	to	the	variable	relationship	of	apathy	and	depression	reported	in	literature	there	is	a	lack	of	consensus	of	the	convergence	of	apathy	and	depression	[57-59].	It	would	therefore	be	beneficial	to	examine	how	apathy	subtypes	and	depression	converge,	as	well	as	diverge,	throughout	disease	progression	to	further	understand	the	complex	relationship	between	these	behaviors.		There	are	limitations	to	this	study.	Due	to	the	nature	of	this	postal	questionnaire	study,	we	were	not	able	to	utilize	the	proposed	diagnostic	criteria	for	apathy	[14].	However,	there	is	remit	to	apply	these	criteria	in	concordance	with	the	DAS	to	refine	apathy	diagnosis.	The	discrepancy	score	between	self-rated	and	informant/carer-rated	DAS	scores	could	be	interpreted	as	anosognosia	in	people	with	AD,	it	could	also	be	due	to	the	influence	of	caregiver	burden	associated	with	this	disease,	which	has	been	shown	to	associate	with	apathy	in	AD	[6].	Future	research	should	explore	how	caregiver	burden	relates	to	different	apathy	subtypes.	Furthermore,	self-rating	depression	and	apathy	could	affect	reliability	of	reporting	due	to	the	severity	of	dementia.	However,	by	including	both	self-rated	and	informant/carer-rated	scales	and	instruments	we	hope	to	ameliorate	the	effects	that	could	occur	in	relation	to	these	two	rating	methods.	A	further	limitation	is	that	there	was	no	formal	assessment	of	cognitive	impairment	performed	on	the	controls	with	only	notes	regarding	this	available	for	these	participants,	making	it	possible	that	some	participants	have	mild	cognitive	impairment.	Further	research	should	look	at	how	cognitive	impairment	associates	with	apathy	subtypes	both	in	patient	populations	and	normative	ageing,	and	determine	the	apathy	subtype	relationships	with	mild	cognitive	impairment.	Additionally,	there	were	no	differences	
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on	medication	status	(cholinergic	and	glutaminergic)	between	apathy	subgroups	within	AD,	but	other	medication	was	not	fully	available	for	participants.	However,	studies	looking	at	medication	effects	on	apathy	are	sparse	and	report	mixed	results,	with	no	studies	looking	directly	at	the	effect	on	apathy	subtypes	[60].	Finally,	while	sample	size	(AD	patient	=	55	and	Carer	=	102)	of	this	study	could	be	cited	as	a	limitation,	however	previous	studies	validating	and	utilizing	apathy	measurement	methods	in	dementia	had	similar	or	smaller	sample	sizes	than	our	current	study,	examples	include	the	LARS	[23],	NPI	[16],	AES	[19]	and	AI	[24].	However,	use	of	the	DAS	in	larger	samples	of	dementia	patients	would	further	the	understanding	of	multidimensional	apathy	in	dementia.		In	conclusion,	the	DAS	was	found	to	be	psychometrically	reliable	and	valid	for	measurement	of	multidimensional	apathy	in	AD.	While	both	versions	were	informative,	the	informant/carer-rated	version	seemed	slightly	more	psychometrically	robust.	While	AD	was	characterized	by	a	Global	apathy	over	all	subtypes,	the	heterogeneity	of	apathy	based	on	subgrouping	within	AD	was	observed.	A	combination	of	Executive	and	Initiation	apathy	was	shown	to	be	central	in	AD,	which	was	further	supplemented	by	an	apathy	subtype	awareness	deficit.	Furthermore,	in	the	scope	of	previous	multidimensional	apathy	research	in	amyotrophic	lateral	sclerosis	and	Parkinson’s	disease	[30,	31],	these	findings	add	to	the	complexities	of	apathy	profiles	and	indicate	a	unique	AD	profile,	further	taking	in	to	account	apathy	subtype	awareness	difficulties.	This	could	prove	clinically	useful	in	distinguishing	it	from	other	neurodegenerative	diseases,	specifically	other	forms	of	dementia.	Further	research	should	investigate	the	degree	of	this	apathy	subtype	awareness	deficit	while	also	determining	the	cognitive	underpinnings	of	different	types	of	apathy	and	pursuing	further	understanding	of	their	impact	on	functional	abilities,	quality	of	life	and	caregiver	burden.		
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Table	1.	Demographics,	apathy	and	depression	scores	for	AD,	informant/carer-
rated	(N=102),	self-rated	(N=55)	and	controls	(N=55)		 Informant/carer-rated	AD	(N=102)	
Self-rated	AD	(N=55)	
Control	(N=55)	 Self-rated	AD	vs	control	p-value	Gender	M/F	 52/50	 28/27	 28/27	 1.000	Age	(mean,	SD)	 78.2	(8.5)	 77.5	(7.9)	 75.0	(6.1)	 0.036	Years	of	Education	(mean,	SD)	 13.2	(3.7)††	 13.3	(3.7)†	 14.4	(3.2)	 0.060		 AES	 51.7	(11.5)	 38.9	(9.0)	 28.8	(5.2)	 <.001	GDS-15	 7.3	(4.4)	 5.1	(4.0)	 1.9	(2.1)	 <.001	LIADL	Score	(mean,	SD)	 3.0	(2.2)	 	 	 	Age	of	onset	(mean,	SD)	years	 74.6	(8.2)†††	 	 	 	Disease	duration	(mean,	SD)	years	 3.9	(2.4)†††	 	 	 	Medication	(Cholinergic/	Glutaminergic/	Both/	None/	Unavailable	%)	
78.4%/	4.9%/	2.9%/	10.8%/	2.9%	
	 	 	
CDR	(0.5/	1/	2/	Unavailable	%)	 43.1%/	39.2%/	14.7%/	2.9%	 	 	 	MMSE	score	(mean,	SD)	 22.0	(5.3)††††	 	 	 	ACE-R	score	(mean,	SD)	 63.3	(18.1)††††	 	 	 	
Significant	values	in	bold.	AD=Alzheimer’s	Disease;	SD=standard	deviation;	AES=Apathy	
Evaluation	Scale;	GDS-15=Geriatric	Depression	Scale-Short	form;	LIADL=Lawton	Instrumental	
Activities	of	Daily	Living;	CDR=	Clinical	Dementia	Rating;	MMSE=	Mini-Mental	State	Exam;	ACE-
R=Addenbrooke’s	Cognitive	Examination-	Revised	
†	N=	39 
††	N=	42	
†††	N=	90	
††††	N=	80	
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Table	2.	Informant/carer-rated	DAS	and	self-rated	DAS	subscale	correlations	
compared	to	standardized	apathy	(AES)	and	depression	(GDS-15)	measures		
Informant/carer (N=102) AES GDS-15 
DAS Executive subscale 0.80*** 0.49*** 
DAS Emotional subscale 0.67*** 0.30** 
DAS Initiation subscale 0.86*** 0.48*** 
DAS Total 0.75*** 0.36*** 
Self (N=55) AES GDS-15 
DAS Executive subscale 0.58*** 0.53*** 
DAS Emotional subscale 0.37* 0.13 
DAS Initiation subscale 0.67*** 0.42** 
DAS Total 0.75*** 0.52*** 
Significant	values	in	bold.	DAS=Dimensional	Apathy	Scale;	AES=Apathy	Evaluation	Scale;	GDS-
15=Geriatric	Depression	Scale-	Short	Form		 	 	 p<.001***,	p<.01**,	p<.05*		
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Table	3.	AD	Class	comparison	on	DAS	subscales,	descriptive	and	clinical	variables	
(informant/carer-rated	N=102)		 Executive	and	Initiation	Apathy		(Class	1)	 Global	Apathy	(Class	2)	 Minimal	Apathy	(Class	3)	 p-value	DAS	Subscale	 	 	 	 	Executive	(mean,	SD)	 17.2	(3.2)	 21.9	(1.5)	 10.6	(4.4)	 <.001	Emotional	(mean,	SD)	 14.6	(3.2)	 18.9	(2.6)	 10.6	(4.0)	 .002	Initiation	(mean,	SD)	 21.1	(1.5)	 23.8	(0.4)	 14.6	(3.2)	 <.001	Descriptive	and	Clinical	 	 	 	 	N	(male	%)	 43	(46.5%)	 29	(44.8%)	 30	(63.3%)	 1.000	Onset	(Early/Late)	 8/35	 4/25	 6/24	 1.000	Age	(mean,	SD)	 78.9	(8.8)	 79.2	(7.3)	 76.2	(8.9)	 1.000	Years	of	Education	(mean,	SD)	 12.7	(3.9)	†	 14.0	(2.9)	††	 13.5	(3.7)	†††	 1.000	AES	(mean,	SD)	 53.2	(4.8)	 63.9	(4.2)	 37.2	(6.0)	 <.001	GDS-15	(mean,	SD)	 8.0	(4.1)	 9.4	(4.0)	 4.3	(3.5)	 .007	LIADL	Score	(mean,	SD)	 3.0	(2.0)	 1.3	(1.4)	 4.4	(2,1)	 .268	Age	of	onset	(mean,	SD)	years	 75.4	(8.5)	‡	 74.3	(7.2)	‡‡	 73.8	(8.9)	‡‡	 1.000	Disease	duration	(mean,	SD)	years	 4.0	(2.3)	‡	 4.7	(2.2)	‡‡	 3.1	(2.3)	‡‡	 1.000	Medication	(Cholinergic/	Glutaminergic/	Both/	None/	Unavailable	%)	
79.1%/	7.0%/	0%/	14.0%/	0%	 72.4%/	3.4%/	6.9%/	13.8%/	3.4%	 83.3%/	3.3%/	3.3%/	6.7%/	3.3%	 1.000	MMSE	score	(mean,	SD)	 22.3	(5.4)	∆∆	 19.9	(5.3)	‡‡‡‡	 24.5	(3.9)	∆	 1.000	ACE-R	score	(mean,	SD)	 64.7	(17.1)	∆∆∆	 56.4	(17.9)	‡‡‡‡	 72.6	(16.7)	‡	 1.000	
Significant	values	in	bold.	AD=Alzheimer’s	Disease;	DAS=Dimensional	Apathy	Scale;	SD=standard	
deviation;	AES=Apathy	Evaluation	Scale;	GDS-15=Geriatric	Depression	Scale-Short	form;	
LIADL=Lawton	Instrumental	Activities	of	Daily	Living;	MMSE=	Mini-Mental	State	Exam;	ACE-
R=Addenbrooke’s	Cognitive	Examination-	Revised	
†	N=	20	
††	N=	5	
†††	N=	17	
‡	N=38	
‡‡	N=26	
‡‡‡‡	N=28	
∆	N=29	
∆∆	N=33		
∆∆∆	N=34		
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Figure	1.	Comparison	of	AD	informant/carer-rated	(N	=	55),	AD	self-rated	(N	=	55)	
and	Control	self-rated	(N	=	55)	groups	on	DAS	subscales	
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Figure	2.	AD	(Informant/carer-rated;	N=102)	subgroupings	(Classes)	based	on	
LCA	of	DAS	Emotional	(x	axis),	DAS	Initiation	(y	axis)	and	DAS	Executive	(z	axis)	
subscale	scores.	
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Supplementary	Table	1.	Informant/carer-rated	DAS	and	self-rated	DAS	subscale	
correlations	compared	to	4	factors	of	the	AES		
Informant/carer (N=102) AES Cognitive 
Factor 
AES Behavior 
Factor 
AES Emotional 
Factor 
AES Other 
Factor 
DAS Executive subscale 0.76*** 0.77*** 0.49*** 0.74*** 
DAS Emotional subscale 0.66*** 0.60*** 0.56*** 0.69*** 
DAS Initiation subscale 0.83*** 0.76*** 0.68*** 0.78*** 
Self (N=55) AES Cognitive 
Factor 
AES Behavior 
Factor 
AES Emotional 
Factor 
AES Other 
Factor 
DAS Executive subscale 0.50** 0.48** 0.24 0.53*** 
DAS Emotional subscale 0.30 0.23 0.46** 0.28 
DAS Initiation subscale 0.56*** 0.64*** 0.38* 0.55*** 
Significant	values	in	bold.	DAS=Dimensional	Apathy	Scale;	AES=Apathy	Evaluation	Scale;	GDS-
15=Geriatric	Depression	Scale-	Short	Form		 	 	 	 p<.001***,	p<.01**,	p<.05*	
 
 
